Expert review of molecular diagnosticsHumansBiomarkersTumorImmunotherapyUrinary Bladder Neoplasms
Urinary biomarkers for immunotherapy response in urothelial carcinoma: current status and future outlook.
Shota Inoue, Marcin Miszczyk, Agata Suleja, Akihiro Matsukawa, Keiichiro Miyajima, Alessandro Dematteis, Angelo Cormio, Navid Roessler, Ahmed R Alfarhan, Ichiro Tsuboi, Tatsushi Kawada, Satoshi Katayama, Takehiro Iwata, Kensuke Bekku, Pierre I Karakiewicz
Published: 202510.1080/14737159.2025.2573459
Abstract
INTRODUCTION: Immunotherapy treatments, such as intravesical Bacillus Calmette-Guérin (BCG) for non-muscle invasive bladder cancer (NMIBC) and systemic immune checkpoint inhibitors (ICIs) for all stages are central to the management of urothelial car…
Preview only. Read the full abstract at the source